Spectroscopic imaging and diagnosis of neoplasia
肿瘤的光谱成像和诊断
基本信息
- 批准号:7119530
- 负责人:
- 金额:$ 141.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-15 至 2008-05-31
- 项目状态:已结题
- 来源:
- 关键词:bioimaging /biomedical imagingbiomarkercervix neoplasmsclinical researchcooperative studydiagnosis design /evaluationearly diagnosisfiber opticshistopathologyhuman subjectimage enhancementimaging /visualization /scanninginterdisciplinary collaborationlight scatteringmathematical modelneoplasm /cancer diagnosisoral pharyngeal neoplasmpatient oriented researchpreneoplastic stateprognosisspectrometrytechnology /technique development
项目摘要
DESCRIPTION (provided by applicant): This is a proposal to the National Institutes of Health to establish a Bioengineering Research Partnership to develop a spectroscopic imaging methodology for diagnosing pre-invasive neoplasia (dysplasia) and monitoring its progression. The proposed program is based on optical spectroscopic clinical instrumentation and associated diagnostic algorithms successfully developed at the MIT Spectroscopy Laboratory. The instrument to be developed will have two components, a system for wide-area imaging of neoplasia, based on light scattering spectroscopy i(LSS), and an optical fiber probe device for studying suspect regions thus revealed, based on tri-modal spectroscopy i(TMS). The goal of the program is to develop and perfect the new technology and assess its application to the diagnosis, characterization, and therapy of neoplastic progression in human patients in real time, The detection and monitoring of neoplastic lesions in the oral cavity and the cervix will be used as model systems for establishing the potential of the technology. In addition, basic studies to further improve the technology and its ability to characterize pre-invasive neoplasia will be conducted. Six projects will be undertaken, each led by an experienced investigator: (I) Prototype instruments and diagnostic algorithms for clinical studies will be developed, maintained and perfected. Clinical studies will be conducted on patients with suspected lesions in the (2) oral cavity and (3) uterine cervix to evaluate and perfect the technology for diagnosing and monitoring dysplasia and predicting the patient's response to chemopreventive and immunotherapeutic agents. Two basic projects aimed at enhancing the diagnostic accuracy of the clinical instrumentation will be undertaken, one (4) to explore the use of quasi-multiple scattered light to enhance the sensitivity and provide depth resolution to LSS imaging, and a second (5) to develop novel spectroscopic end-points based on well-characterized molecular and cellular events associated with the progression and regression of disease. (6) Pathology support activities will include analysis of oral and cervical tissues for molecular markers, and analysis of histologic sections of the same biopsy tissue by computer-assisted quantitative image analysis. An administrative core will coordinate the multidisciplinary activities of the program and insure information sharing and efficient communication. The partnership, composed of expert investigators at six institutions, will include experienced bioengineers with training in physics and mechanical/electrical engineering, pathologists experienced in cancer research, and hospital-based clinicians specializing in oral and cervical dysplasia.
描述(由申请人提供):这是一项向国家卫生研究院提出的建议,旨在建立生物工程研究伙伴关系,以开发一种光谱成像方法来诊断侵袭前肿瘤(异型增生)并监测其进展。该计划基于麻省理工学院光谱学实验室成功开发的光学光谱学临床仪器和相关诊断算法。将要开发的仪器将有两个组成部分,一个是基于光散射光谱I(LSS)的肿瘤广域成像系统,另一个是基于三模光谱I(TMS)的用于研究可疑区域的光纤探头设备。该计划的目标是开发和完善这项新技术,并评估其在人类患者肿瘤进展的诊断、特征和治疗中的应用。口腔和宫颈肿瘤病变的检测和监测将被用作建立该技术潜力的模型系统。此外,还将进行基础研究,以进一步提高该技术及其表征侵袭前肿瘤的能力。将开展六个项目,每个项目由一名经验丰富的调查员领导:(I)将开发、维护和完善临床研究的原型仪器和诊断算法。将对(2)口腔和(3)宫颈可疑病变的患者进行临床研究,以评估和完善诊断和监测异型增生以及预测患者对化学预防和免疫治疗药物的反应的技术。将开展两个旨在提高临床仪器诊断准确性的基本项目,一个(4)探索使用准多重散射光来提高LSS成像的灵敏度和提供深度分辨率,以及(5)基于与疾病进展和消退相关的特征良好的分子和细胞事件开发新的光谱终点。(6)病理学支持活动将包括对口腔和宫颈组织进行分子标记分析,以及利用计算机辅助定量图像分析对同一活检组织的组织切片进行分析。行政核心将协调该方案的多学科活动,并确保信息共享和有效沟通。这一伙伴关系由来自六个机构的专家调查人员组成,其中将包括在物理和机械/电气工程方面接受过培训的经验丰富的生物工程师,在癌症研究方面经验丰富的病理学家,以及专门从事口腔和宫颈发育不良的医院临床医生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL Stephen FELD其他文献
MICHAEL Stephen FELD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL Stephen FELD', 18)}}的其他基金
MONTE CARLO MODELLING OF TRI-MODAL SPECTROSCOPY SPECTRA FOR DETECTION OF EARLY
用于早期检测的三模态光谱的蒙特卡罗建模
- 批准号:
7723212 - 财政年份:2008
- 资助金额:
$ 141.56万 - 项目类别:
MONTE CARLO MODELLING OF TRI-MODAL SPECTROSCOPY SPECTRA FOR DETECTION OF EARLY
用于早期检测的三模态光谱的蒙特卡罗建模
- 批准号:
7601475 - 财政年份:2007
- 资助金额:
$ 141.56万 - 项目类别:
PHOTON MIGRATION IN TURBID MEDIA: FORWARD & INVERSE MODELS
浑浊介质中的光子迁移:向前
- 批准号:
6615296 - 财政年份:2002
- 资助金额:
$ 141.56万 - 项目类别:
In Situ Raman Spectroscopic Analysis of Arterial Disease
动脉疾病的原位拉曼光谱分析
- 批准号:
6642784 - 财政年份:2001
- 资助金额:
$ 141.56万 - 项目类别:
相似国自然基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
- 批准号:61602201
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
生物标志物NGAL和KIM-1分子在急性肾损伤中的作用机制研究及标志物联合检测对早期诊断AKI的作用
- 批准号:81101308
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
- 批准号:81170309
- 批准年份:2011
- 资助金额:50.0 万元
- 项目类别:面上项目
精神分裂症记忆障碍的脑网络组学研究
- 批准号:91132301
- 批准年份:2011
- 资助金额:350.0 万元
- 项目类别:重大研究计划
卵巢癌血浆microRNA潜在标志物筛选及调控机制研究
- 批准号:81072363
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
高原人群创伤性深静脉血栓血浆预测诊断蛋白标记物的发掘
- 批准号:81060151
- 批准年份:2010
- 资助金额:25.0 万元
- 项目类别:地区科学基金项目
非小细胞肺癌Biomarker的Imaging MS研究新方法
- 批准号:30672394
- 批准年份:2006
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
酸化ストレス応答アポトーシス誘導蛋白のUCに対する新規Biomarker探索と治療への展開
寻找治疗 UC 的氧化应激反应性凋亡诱导蛋白的新生物标志物并开发治疗方法
- 批准号:
24K11919 - 财政年份:2024
- 资助金额:
$ 141.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
肝内胆管癌新規Biomarkerの同定及び癌周囲間質を標的とした新規治療開発
鉴定肝内胆管癌的新型生物标志物并开发针对癌周基质的新疗法
- 批准号:
24K19350 - 财政年份:2024
- 资助金额:
$ 141.56万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
収縮能が保たれた心不全の機械学習分類とmicroRNAなどのbiomarkerの探索
机器学习对具有保留收缩性的心力衰竭进行分类并搜索 microRNA 等生物标志物
- 批准号:
24K19007 - 财政年份:2024
- 资助金额:
$ 141.56万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 141.56万 - 项目类别:
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
$ 141.56万 - 项目类别:
Research Grant
Sleep and circadian dysfunction in ageing and neurodegeneration: a life course and biomarker study of the British 1946 birth cohort.
衰老和神经退行性疾病中的睡眠和昼夜节律功能障碍:对英国 1946 年出生队列的生命历程和生物标志物研究。
- 批准号:
MR/Y009452/1 - 财政年份:2024
- 资助金额:
$ 141.56万 - 项目类别:
Fellowship
Naturalistic Social Communication in Autistic Females: Identification of Speech Prosody Markers
自闭症女性的自然社交沟通:语音韵律标记的识别
- 批准号:
10823000 - 财政年份:2024
- 资助金额:
$ 141.56万 - 项目类别:
Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy (LIVERAIM)
基于生物标志物的慢性肝病早期诊断平台,以实现个性化治疗(LIVERAIM)
- 批准号:
10087822 - 财政年份:2024
- 资助金额:
$ 141.56万 - 项目类别:
EU-Funded
Enhanced stratification of COPD patients via integration of a digitally enabled biomarker Point-of-Care test within a Remote Patient Monitoring tool
通过在远程患者监测工具中集成数字化生物标志物即时检测,增强 COPD 患者的分层
- 批准号:
10098600 - 财政年份:2024
- 资助金额:
$ 141.56万 - 项目类别:
Collaborative R&D
QuBIE: Quantitative Biomarker Identification for Non-Endoscopic Prediction and Monitoring of Treatment Response in Eosinophilic Oesophagitis
QuBIE:用于非内镜预测和监测嗜酸性食管炎治疗反应的定量生物标志物鉴定
- 批准号:
10083253 - 财政年份:2024
- 资助金额:
$ 141.56万 - 项目类别:
Collaborative R&D














{{item.name}}会员




